These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context. Simon S; Mueller SO Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649 [TBL] [Abstract][Full Text] [Related]
24. Effect of bisphenol A, tetrachlorobisphenol A and pentachlorophenol on the transcriptional activities of androgen receptor-mediated reporter gene. Sun H; Xu LC; Chen JF; Song L; Wang XR Food Chem Toxicol; 2006 Nov; 44(11):1916-21. PubMed ID: 16893599 [TBL] [Abstract][Full Text] [Related]
25. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation. Genady AR Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives. Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226 [TBL] [Abstract][Full Text] [Related]
27. 11beta-alkyl-Delta9-19-nortestosterone derivatives: high-affinity ligands and potent partial agonists of the androgen receptor. Muddana SS; Price AM; MacBride MM; Peterson BR J Med Chem; 2004 Oct; 47(21):4985-8. PubMed ID: 15456242 [TBL] [Abstract][Full Text] [Related]
28. Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators. Hamann LG; Manfredi MC; Sun C; Krystek SR; Huang Y; Bi Y; Augeri DJ; Wang T; Zou Y; Betebenner DA; Fura A; Seethala R; Golla R; Kuhns JE; Lupisella JA; Darienzo CJ; Custer LL; Price JL; Johnson JM; Biller SA; Zahler R; Ostrowski J Bioorg Med Chem Lett; 2007 Apr; 17(7):1860-4. PubMed ID: 17292608 [TBL] [Abstract][Full Text] [Related]
29. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827 [TBL] [Abstract][Full Text] [Related]
30. Preparation and evaluation of carborane analogues of tamoxifen. Beer ML; Lemon J; Valliant JF J Med Chem; 2010 Nov; 53(22):8012-20. PubMed ID: 21028825 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide. Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829 [TBL] [Abstract][Full Text] [Related]
33. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040 [TBL] [Abstract][Full Text] [Related]
34. New estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Endo Y; Yoshimi T; Yamakoshi Y Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):312-4. PubMed ID: 10705532 [TBL] [Abstract][Full Text] [Related]
35. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists. Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Lundeen SG; Sui Z Bioorg Med Chem Lett; 2007 Feb; 17(4):955-8. PubMed ID: 17134895 [TBL] [Abstract][Full Text] [Related]
36. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist. Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057 [TBL] [Abstract][Full Text] [Related]
37. The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening. Lanter JC; Fiordeliso JJ; Jiang W; Allan GF; Lai MT; Linton O; Hahn do W; Lundeen SG; Sui Z Bioorg Med Chem Lett; 2007 Jan; 17(1):123-6. PubMed ID: 17071085 [TBL] [Abstract][Full Text] [Related]
38. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones. van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838 [TBL] [Abstract][Full Text] [Related]
39. A cellular conformation-based screen for androgen receptor inhibitors. Jones JO; Diamond MI ACS Chem Biol; 2008 Jul; 3(7):412-8. PubMed ID: 18582038 [TBL] [Abstract][Full Text] [Related]
40. C19-steroids as androgen receptor modulators: design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists. Marwah P; Marwah A; Lardy HA; Miyamoto H; Chang C Bioorg Med Chem; 2006 Sep; 14(17):5933-47. PubMed ID: 16759873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]